Does current pharmacologic management for patients aged ≥ 65 years with HFrEF align with Canadian guidelines?
There is a significant gap in care regarding the implementation of guideline-directed medical therapy for older patients with HFrEF in Canada.
Current pharmacologic management for patients with HFrEF does not align with the Canadian guidelines. Given this gap in care, innovative strategies to optimize care in patients with HFrEF are needed.
Wahid et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: